Quest for the right Drug
פליט אנמה 133 FLEET ENEMA 133 (SODIUM PHOSPHATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
רקטלי : RECTAL
צורת מינון:
חוקן : ENEMA
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Fleet Enema 133 is well tolerated when used as indicated. However, adverse events possibly associated with the use of Fleet Enema 133 have been infrequently reported. In some cases, adverse events may occur, especially if the enema is misused. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Organized by MedDRA System Organ Class the undesirable effects are listed below using the following frequency classification: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data): Immune System Disorders Very rare: hypersensitivity e.g. urticaria Skin and subcutaneous tissue disorders Very rare: blister, pruritus, stinging. Metabolism and nutrition disorders Very rare: dehydration, hyperphosphataemia, hypocalcaemia, hypokalaemia, hypernatraemia, metabolic acidosis. Gastrointestinal disorders Very rare: nausea, vomiting, abdominal pain, abdominal distension, diarrhoea, gastrointestinal pain, anal discomfort and proctalgia. General disorders and administration site conditions Very rare: rectal irritation, pain, stinging, chills. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
Laxative (hyperosmotic, saline), preparation for rectal examinations
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף